Cancer Screening Blood Tests for Men: What the Numbers Can and Can't Tell You

Most men who book a full body checkup in Mumbai ask the same question at our counter: should I add a cancer screening blood test to it? The panels exist and the idea sounds reassuring. But here is the honest answer, worth reading before you spend the money: tumor marker blood tests are built to monitor a cancer that is already known, not to screen healthy people. The one genuine exception is PSA, and even that starts with a conversation, not a test.

PSA: the one marker men actually get tested for

PSA, the prostate-specific antigen, is the only cancer marker that guideline bodies seriously discuss as a screening test for men. And they are careful about it.

The U.S. Preventive Services Task Force says men between 55 and 69 should make an individual decision about PSA testing after talking through the benefits and risks with their doctor, and that men over 70 should not be screened routinely. The American Cancer Society puts the conversation earlier: starting at 50 for average-risk men, 45 if the risk is high, 40 for the very high-risk. The American Urological Association suggests a baseline PSA between 45 and 50. The ages differ, but every guideline agrees on the shape of the decision: it is made with a doctor, not by a checkbox on a checkup form.

The caution exists for a reason. PSA rises in prostate cancer, but also in benign prostate enlargement and prostate inflammation. A high number is a signal to look closer, never a verdict. Doctors sometimes check free PSA alongside total PSA when the total sits in the gray zone, which helps decide who needs a biopsy.

Getting a PSA blood test

Do: have the talk first. Know your family history and what you would actually do with the result before the needle goes in. A test you would not act on is just a worry you paid for.

Don't: read the report like a verdict. A slightly raised PSA is common; a calm retest beats a panic-driven scan booked on your own.

More detail lives in our PSA testing after 50 guide; the test itself is PSA Total (Prostate Marker).

The markers inside most men's cancer panels

A men's cancer panel like our Cancer Detection Panel - Male bundles a few of the classic tumor markers into one blood draw. Each has a real job. Screening healthy people is not it.

CEA (carcinoembryonic antigen) is the colorectal cancer marker. Mayo Clinic Laboratories states it plainly: CEA is useful for monitoring colorectal cancer and checking how treatment is working, and it is not useful for screening the general population. Smokers often run mildly high, and liver or bowel inflammation can lift it too. Most healthy nonsmokers sit at or below 3.0 ng/mL. (Ranges vary by laboratory, so your report's own range is the one that counts.)

CA 19-9 is the pancreatic cancer marker. It is not a screening test either. Doctors use it to track known pancreatic cancer and watch for recurrence after treatment. It also rises with gallstones, pancreatitis and bile-duct infections, and about five in every hundred people do not produce the antigen at all. Its usual reference sits under 35 U/mL.

AFP (alpha-fetoprotein) watches over liver cancer in high-risk patients and certain testicular tumors. It is not a general screening test either; we covered it properly in our AFP blood test guide.

Each of these markers can be genuinely useful. They are just useful in the wrong context when they are sold as general cancer screening.